Langerhans cell sarcoma

American Journal of Dermatopathology

Volumn 28, Issue 1, 2006, Pages 36-39

  Ferringer, Tammie ^a   Banks, Peter M ^b   Metcalf, John S ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Dendritic cells; Histiocytosis; Langerhans cell; Langerhans cell sarcoma

Indexed keywords

CD31 ANTIGEN; DOXORUBICIN; IFOSFAMIDE; ALKYLATING AGENT; ANTINEOPLASTIC ANTIBIOTIC;

ADULT; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; CYTOLOGY; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LYMPH NODE; MALE; PRIORITY JOURNAL; SARCOMA; ULTRASTRUCTURE; DISEASE FREE SURVIVAL; HISTIOCYTOSIS X; MALIGNANT HISTIOCYTOSIS; METASTASIS; PATHOLOGY; REMISSION; SKIN TUMOR;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; DISEASE-FREE SURVIVAL; DOXORUBICIN; HISTIOCYTOSIS, LANGERHANS-CELL; HISTIOCYTOSIS, MALIGNANT; HUMANS; IFOSFAMIDE; LANGERHANS CELLS; LYMPH NODES; MALE; REMISSION INDUCTION; SARCOMA; SKIN NEOPLASMS;

EID: 33745961511     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000146314.52378.c2     Document Type: Article

References (21)

1. Bonetti F, Knowles DM, Chilosi M, et al. A distinctive cutaneous malignant neoplasm expressing the Langerhans cell phenotype. Cancer. 1985;55:2417-2425.
2. Lieberman PH, Jones CR, Steinman RM, et al. Langerhans cell (eosinophilic) granulomatosis: a clinicopathologic study encompassing 50 years. Am J Surg Pathol. 1996;20:519-552.
3. Frishberg Y, Stark B, Mor C, et al. Soft tissue mass as a presenting symptom in Langerhans cell histiocytosis. Pediatr Hematol Oncol. 1988;5:319-324.
4. Jaffe E, Harris N, Stein H, et al. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: WHO Classification IARC Press; 2001:273-283.
5. Al-Abbadi M, Masih A, Braylan RC, et al. Soft tissue Langerhans' cell histiocytosis in an adult: a case presentation with flow cytometric analysis and literature review. Arch Pathol Lab Med. 1997;121:169-172.
6. Delabie J, Wolf-Peeters CD, Vos RD, et al. True histiocytic neoplasm of Langerhans' cell type. J Pathol. 1991;163:217-223.
7. Gonzalez CL, Jaffe ES. The histiocytoses: clinical presentation and differential diagnosis. Oncology. 1990;4:47-62.
8. Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41:1-29.
9. Lauritzen AF, Ralfkiaer E. Histiocytic sarcomas. Leuk Lymphoma. 1995;18:73-80.
10. Pillay K, Solomon R, Daubenton JD, et al. Interdigitating dendritic cell sarcoma: a report of four paediatric cases and review of the literature. Histopathology. 2004;44:283-291.
11. Tani M, Ishii N, Kumagai M, et al. Malignant Langerhans cell tumour. Br J Dermatol. 1992;126:398-403.
12. Warnke RA, Weiss LM, Chan JKC, et al. Tumors of the Lymph Nodes and Spleen. Atlas of Tumor Pathology. 3rd Series, Fascicle 14. Washington, DC: Armed Forces Institute of Pathology; 1995: 341-384.
13. McDermott R, Bausinger H, Fricker D, et al. Reproduction of Langerin/CD207 traffic and Birbeck granule formation in a human cell line model. J Invest Dermatol. 2004;123:72-77.
14. Lauritzen AF, Delsol G, Ebbe Hansen N, et al. Histiocytic sarcomas and monoblastic leukemias: a clinical, histologic, and immunophenotypical study. Am J Clin Pathol. 1994;102:45-54.
15. Itoh H, Miyaguni H, Kataoka H, et al. Primary cutaneous Langerhans cell histiocytosis showing malignant phenotype in an elderly woman: Report of a fatal case. J Cutan Pathol. 2001;28:371-378.
16. Elleder M, Fakan F, Hula M. Pleomorphous histiocytic sarcoma arising in a patient with Histiocytosis X. Neoplasma. 1986;33:117-127.
17. Willman CL, Busque L, Griffith BB, et al. Langerhans'-Cell Histiocytosis (Histiocytosis X)-a clonal proliferative disease. N Engl J Med. 1994;331:154-160.
18. Ben Ezra J, Bailey A, Azumi N, et al. Malignant Histiocytosis X: a distinct clinicopathologic entity. Cancer. 1991;68:1050-1060.
19. Wood C, Wood GS, Deneau DG, et al. Malignant Histiocytosis X: report of a rapidly fatal case in an elderly man. Cancer. 1984;54:347-352.
20. Misery L, Godard W, Hamzeh H, et al. Malignant Langerhans cell tumor: a case with a favorable outcome associated with the absence of blood dendritic cell proliferation. J Am Acad Dermatol. 2003;49:527-529.
21. Slone SP, Fleming DR, Buchino JJ. Sinus histiocytosis with massive lymphadenopathy and Langerhans cell histiocytosis express the cellular adhesion molecule CD31. Arch Pathol Lab Med. 2003;127:341-344.